Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) causes late-term abortion in sows and respiratory disease in young pigs (Christianson et ai., 1993; Christianson et ai., 1992; Rossow et ai., 1995) . Following infection, PRRSV replicates in lungs and secondary lymphoid tissues in the host and establishes a viremic period of about 3-4 weeks (Duan, Nauwynck, and Pensaert, 1997; Rossow et ai., 1994; Rossow et ai., 1995) . The viremic period is followed by a persistent period of 1-6 months, characterized by low levels of virus replication in secondary lymphoid tissues (Allende et ai., 2000) . The host immune response usually takes several months to clear the virus from persistently infected swine (Allende et ai., 2000) .
Previous studies demonstrated that the adaptive immune responses against PRRSV develop gradually, an important factor in less efficient clearance of the virus from the host (Allende et ai., 2000; Meier et ai., 2003) . The ineffective adaptive immune responses against PRRSV are the result of various immune evasion strategies utilized by this virus (Ansari et ai., 2006; Beura et ai., 2010; Costers et aI., 2009; Lopez and Osorio, 2004; Ostrowski et ai., 2002; Subramaniam et ai., 2010; Vu et ai., 2011) . One such strategy consists of inhibiting the key pro-inflammatory cytokine, tumor necrosis factor-Cf (TNF-Cf) in infected cells (Lopez-Fuertes et ai., 2000; Subramaniam et ai., 2010) . The TNF-Cf response against different PRRSV strains in pulmonary alveolar macrophages (PAMs) varies significantly depending on the strain (Darwich et ai., 2011; Gimeno et ai., 2011) . Since TNF-Cf can inhibit PRRSV replication in macrophages (Lopez-Fuertes et ai., 2000) , we hypothesize that PRRSV-mediated TNF-Cf suppression would likely enhance virus production in the infected host.
Our laboratory has previously shown that PRRSV-vFL12 strain suppresses TNF-Cf during infection, at the promoter level and also post-transcriptionally (Subramaniam et ai., 2010) . Particularly, vFL12 strain suppresses the TNF-Cf promoter only at early times after infection. Even though TNF-Cf transcripts are abundant at later time points after vFL12 infection, secreted TNF-Cf is not detected in the infected culture supernatants (Subramaniam et ai., 2010) . The non-structural proteins 1Cf (NsplCf) and 1 ~ (Nsp1~) of the virus down-regulate NF-KB and Sp1 activities at TNF-Cf promoter, respectively (Subramaniam et ai., 2010) . In addition to Nsp1 proteins, PRRSV non-structural protein 2 (Nsp2) also regulates TNF-Cf expression in infected cells (Chen et ai., 2010) . The variations in Nsp2 sequences account for differences in TNF-Cf induction in response to various PRRSV field isolates (Darwich et ai., 2011) .
Nsp1a and Nsp1b are non-structural proteins that participate in various aspects of the PRRSV life cycle such as transcription, virion biogenesis and innate immune evasion Kroese et al., 2008; Tijms et al., 2007) . Nsp1a, the proteolytically processed amino-terminal region of Nsp1, contains 180 amino acid residues and forms two domains, an N-terminal zinc finger domain (ZF domain) and a C-terminal papain-like cysteine protease (PCPa) domain (Sun et al., 2009 ). Nsp1b, the proteolytically processed carboxy-terminal region of Nsp1, contains 203 amino acid residues and forms three domains, an N-terminal nuclease domain, a linker domain and a C-terminal papain-like cysteine protease (PCPb) domain (Xue et al., 2010) . The PCPa and PCPb domains auto-cleave Nsp1a and Nsp1b from the viral polyprotein, respectively (Kroese et al., 2008) . Upon cleavage and activation, both of these proteins homo-dimerize (Sun et al., 2009; Xue et al., 2010) . PCPa-mediated auto-cleavage of Nsp1a is essential for transcription of viral sub-genomic RNAs (Kroese et al., 2008) . Likewise, PRRSV Nsp1a ZF domain may also directly participate in viral transcription (Fang and Snijder, 2010; Tijms et al., 2007) . On the other hand, PCPb-mediated auto-cleavage of Nsp1b is essential for PRRSV replication (Kroese et al., 2008) . In addition, the Nsp1b nuclease domain cleaves double-stranded DNA, and singlestranded RNA in vitro (Xue et al., 2010) . However, the Nsp1a and Nsp1b sequences necessary for down-regulating the TNF-a promoter activity are unknown.
In this study, we conducted mutagenesis studies to identify the amino acid residues in Nsp1a and Nsp1b that are necessary for affecting TNF-a promoter activity. Five Nsp1a amino acid residues, Gly90, Asn91, Arg97, Arg100, and Arg124 were identified as required for suppression of TNF-a promoter activity. Several Nsp1b amino acid residues spanning the entire protein were found to be necessary for suppression of TNF-a promoter activity. We subsequently recovered two mutant viruses from infectious cDNA clones with alanine substitution at Nsp1a Gly90 residue or Nsp1b 70-74 amino acid positions. These mutant viruses induced TNF-a mRNAs efficiently but induced protein levels minimally in infected macrophages when compared to the infection with wild type virus. In infected swine, the Nsp1b mutant virus exhibited growth-attenuated phenotype as compared to the wild type virus. Overall, these results suggest the possibility of generating attenuated PRRSVs for vaccine development through mutations in Nsp1b.
Results
Cysteine protease activities of Nsp1 are not necessary for TNF-a promoter suppression Nsp1a and Nsp1b cysteine protease activities are mediated by PCPa and PCPb, respectively (Kroese et al., 2008) . The histidine residue at amino acid position 146 in vFL12-Nsp1a is a part of PCPa active site as deduced by pairwise sequence alignment with Nsp1a of Lelystad strain (Kroese et al., 2008) . Similarly, the cysteine residue at amino acid position 90 and the histidine residue at amino acid position 159 of vFL12-Nsp1b are part of the PCPb active site, as deduced by pairwise sequence alignment with Nsp1b of Lelystad strain (Kroese et al., 2008) . Mutation of these residues to alanine in the expression constructs did not affect their respective protein levels ( Fig. 1A and B, bottom panels). Transient reporter assays were carried out with a TNF-a promoter-luciferase construct and lipopolysaccharide (LPS) was used to stimulate the promoter. Both Nsp1a and Nsp1b mutated in their respective cysteine protease active sites (PCPa and PCPb, respectively) efficiently reduced the TNF-a promoter activity in those assays when compared to their wild type counterparts (Fig. 1A, B) . The results suggest that Nsp1a and Nsp1b reduce the TNF-a promoter activity independently of their cysteine protease activities.
Identification of Nsp1a amino acid residues critical for TNF-a promoter suppression Nsp1a has two distinct domains: the ZF domain (1-65 amino acids) and the PCPa domain (66-166 amino acids) (Sun et al., 2009) . To identify which of these domains is necessary for reducing TNF-a promoter activity, we performed alanine-scanning mutagenesis in randomly selected blocks of 4-6 amino acid length spanning the entire Nsp1a protein. In transient reporter assays, none of the PCPa domain mutants were able to reduce TNF-a promoter activity ( Fig. 2A) . Certain PCPa domain mutants such as Nsp1a122-6A, Nsp1a139-5A, and Nsp1a155-5A exhibited reduced protein levels when compared to the wild type protein ( Fig. 2A) . Three out of four ZF domain mutants (Nsp1a20-4A, Nsp1a55-5A, and Nsp1a63-5A) reduced the TNF-a promoter activity to similar extent as the wild type protein (Fig. 2A) . The remaining ZF domain mutant (Nsp1a41-5A) suppressed the TNF-a promoter less efficiently than did the wild type protein, which may be due to reduced protein expression ( Fig. 2A) . Three amino acid scanning mutations in PCPa domain but not in the ZF domain also relieved TNF-a promoter suppression (data not shown). These results suggest that the PCPa domain but not ZF domain appears to be primarily responsible for suppression of TNF-a promoter activity.
Additional studies were performed to identify individual amino acid residues in PCPa domain that are necessary for reducing TNF-a promoter activity. Point mutations were introduced in selected amino acid stretches 89-93, 95-97, and 122-127 of PCPa domain. Mutation of PCPa domain residues, Gly90, Asn91, Arg97, Arg100, and Arg124 significantly up regulated TNFa promoter activity when compared to the wild type protein (Fig. 2B, C) . Mutations of these amino acid residues did not affect protein levels ( Fig. 2B and C) or protease activities of Nsp1a (data not shown). Examination of the Nsp1a tertiary structure revealed that the amino acid residues, Gly90, Asn91, Arg97, Arg100, and Arg124 are closely positioned on PCPa domain surface (Fig. 2D ). These studies suggest that the five amino acid residues in PCPa domain, Gly90, Asn91, Arg97, Arg100, and Arg124 are important for suppressing the TNF-a promoter activity.
Mutations in several Nsp1b amino acid stretches relieved TNF-a promoter suppression
Nsp1b has three domains: an N-terminal nuclease domain (1-48 amino acids), a flexible linker domain (49-84 amino acids) and a C-terminal PCPb domain (85-181 amino acids) (Xue et al., 2010) . To identify the domains involved in suppressing the TNF-a promoter activity, alanine-scanning mutations of 4-6 amino acids in all Nsp1b domains were introduced. In transient reporter assays, most mutant proteins demonstrated relief of TNF-a promoter suppression relative to the wild type protein (Fig. 3) . The mutant, Nsp1b101-5A suppressed TNF-a promoter moderately when compared to the wild type protein (Fig. 3) . Although the mutants, Nsp1b124-4A and Nsp1b136-5A, were expressed at reduced protein levels when compared to the wild type protein (Fig. 3) , the relief of TNF-a promoter suppression activity was significant. The results suggest that all Nsp1b domains may be Fig. 2 . Characterization of Nsp1a amino acid residues necessary for reducing TNF-a promoter activity. (A-C) RAW 264.7 cells were transfected with pswTNF-luc (0.2 mg) along with Nsp1a wild type or mutant protein expressing plasmid (1 mg) and a renilla luciferase-expressing vector (10 ng). After 24 h, cells were stimulated with LPS (1 mg/ mL) for 6 h. Firefly luciferase activities were measured in cell lysates and normalized with renilla luciferase activities. 100% TNF-a promoter activity represents the activity in control vector transfected cells and 0% promoter activity represents the activity in wild type Nsp1a transfected cells. Each bar represents mean 7standard error (n ¼3). The immunoblot panels depict the amount of corresponding viral proteins in transfected cells. RAW 264.7 cells were transfected with Nsp1a wild type or mutant protein expressing plasmid (2 mg). After 24 h post-transfection, the viral protein in cell lysates was detected by western blotting using anti-Nsp1 antibodies. b-actin was used as loading control. (D) Tertiary structure of Nsp1a. Residues necessary for reducing TNF-a promoter activity are highlighted: Three Arginine residues (in green), the Glycine residue (in yellow) and the Asparagine residue (in blue). The figure was adopted from NCBI structure database (PDB ID: 3IFU) using Cn3D software. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) involved in inhibiting TNF-a promoter activity. Alternatively, it is possible that mutations in some of these domains may have affected the overall structure of the protein, thus rendering it nonfunctional in its ability to suppress TNF-a promoter activity.
Recovery, growth kinetics and plaque morphology of Nsp1a and Nsp1b mutant viruses
In the case of Nsp1a, attempts were made to recover viruses harboring 3-6 amino acid block mutations from infectious cDNA clones containing the mutations. Viruses with mutations at the Nsp1a positions, 89-93, 95-97, 97-100, and 122-127 were nonviable as judged by the absence of anti-N (PRRSV nucleocapsid) immunofluorescence (Table 1) in cells infected with supernatants from full-length viral RNA transfected cells. However, two viruses (vFL12Nsp1aG90A and vFL12Nsp1aG90S) were recovered with single point mutations at Nsp1a amino acid residue, Gly90 (Table 1) . Viruses harboring other single point mutations at Nsp1a amino acid residues, Asn91, Arg97, Arg100, and Arg124 were not viable (Table 1 ).
In the case of Nsp1b, attempts were made to generate viruses with mutations at Nsp1b positions, 70-74 and 113-118. The infectious virus was successfully recovered with mutations at residues 70-74 (vFL12Nsp1b70-5A) but a viable virus could not be recovered with mutation at residues 113-118 (Table 1) . In an attempt to recover a virus containing mutations in both Nsp1a G90 and Nsp1b positions 70-74, we generated cDNA clones with these mutations. However, repeated attempts to recover such a virus were unsuccessful. Overall, we recovered three mutant PRRSVs, two presenting mutations in Nsp1a at G90 (G90A, G90S) and one with a mutation in Nsp1b at positions, 70-74. Of the two Nsp1a mutant viruses, we used the virus with G90S substitution for further studies, as this mutant virus contains two nucleotide substitutions in this codon and is therefore less likely to readily revert to the wild type sequence.
Multi-step growth kinetic analysis revealed that the mutant viruses (vFL12Nsp1aG90S and vFL12Nsp1b70-5A) exhibited overall similar growth kinetics as the parental wild type vFL12 264.7 cells were transfected with pswTNF-luc (0.2 mg) along with Nsp1b wild type or mutant expressing plasmid (1 mg) and a renilla luciferase vector (10 ng). After 24 h, cells were stimulated with LPS (1 mg/mL) for 6 h. Firefly luciferase activities were measured in cell lysates and normalized with renilla luciferase activities. 100% TNF-a promoter activity represents the activity in control vector transfected cells and 0% promoter activity represents the activity in wild type Nsp1b transfected cells. Each bar represents mean 7 standard error (n¼ 3). Bottom panels depict the amount of corresponding viral proteins in transfected cells. RAW 264.7 cells were transfected with Nsp1b wild type or mutant expressing plasmid (2 mg).
After 24 h post-transfection, the viral protein in cell lysates was detected by western blotting using anti-Nsp1 antibodies. b-actin was used as loading control. 
a Number in the parentheses indicate the position of amino acids mutated to alanines. in MARC-145 cells. The vFL12Nsp1b70-5A virus grew slightly slower than vFL12 virus exhibiting approximately a ten-fold difference in titer (Fig. 4A ). The vFL12Nsp1aG90S virus grew to a titer that is approximately 5-7 fold less compared to vFL12 (Fig. 4A ). Both mutant viruses also exhibited reduced plaque sizes as compared to the wild type virus (Fig. 4B) . Overall, these results suggest that the mutant viruses, vFL12Nsp1aG90S and vFL12Nsp1b70-5A, exhibit somewhat reduced growth in cultured MARC-145 cells.
Expression of TNF-a in macrophages infected by Nsp1 mutant PRRSVs is up regulated
Studies were performed to examine TNF-a responses after infecting swine macrophages with vFL12 wild type or the mutant viruses. Infections with Nsp1 mutant viruses induced higher levels of TNF-a mRNAs only at 12 hpi when compared to the infection with the wild type virus (Fig. 5A) . Importantly, the mutant virus vFL12Nsp1b70-5A induced significant levels of TNF-a mRNA at the early (12 hpi) time of infection (Fig. 5A) . However, there were no differences observed in TNF-a mRNA levels between wild type and mutant virus infected macrophage cultures at 24 hpi (Fig. 5A ). Our additional experiments also showed that the Nsp1b70-5A mutant protein did not affect Sp1-dependent transcriptional activities in transient transfection assays (data not shown), which are necessary for activating the TNF-a promoter (Falvo et al., 2000) . The mutant vFL12Nsp1aG90S virus induced higher levels of TNF-a protein in the supernatant of infected macrophage cultures both at 12 and 24 hpi (Fig. 5B) . However, both wild type vFL12 and mutant vFL12Nsp1b70-5A viruses induced negligible levels of TNF-a protein in the supernatant of infected macrophage cultures (Fig. 5B) .
Furthermore, the mutant viruses, replicated with low viral titers in macrophage cultures after infection when compared to wild type vFL12 (Fig. 5C ). In particular, the mutant vFL12Nsp1b70-5A showed an approximately 100-fold reduction in viral titers in macrophage culture supernatants when compared to vFL12 (Fig. 5C) .
Additionally, the macrophages infected with the mutant viruses also induced higher mRNA levels of two pro-inflammatory chemokines: CCL2 and CXCL10 at 24 and 36 h post-infection when compared to macrophages infected with vFL12 (data not shown). This is not unexpected considering that these two chemokines are induced by TNF-a (Murao et al., 2000; Qi et al., 2009) . In summary, the two mutant viruses, vFL12Nsp1aG90S and vFL12Nsp1b70-5A, stimulated the production of TNF-a mRNA and protein more strongly than the wild type vFL12 in infected macrophage cultures.
Growth attenuation and TNF-a induction phenotypes of PRRSV mutant viruses in infected pigs
To examine the growth of the Nsp1 mutant viruses and TNF-a responses in swine, pigs were infected with wild type vFL12 or the mutant viruses. By 14 day post-infection (dpi), all infected pigs seroconverted (data not shown). In addition, all infected pigs exhibited their peak viremia between 3 and 7 day post-infection ( Fig. 6A, B) . Sequencing of viral RNAs isolated from serum until 14 day postinfection confirmed the presence of Nsp1aG90S and Nsp1b70-5A mutations in respective mutant viruses. When compared to wild type vFL12, the mutant vFL12Nsp1b70-5A exhibited nearly two log 10 reduction in viral titers and viral RNA copies in serum at 3 dpi (Fig. 6A, B) . By 7 dpi, two out of three animals infected with the mutant vFL12Nsp1b70-5A had no detectable infectious virus in serum (Fig. 6A) . However, viral RNAs were detected at lower levels in pigs infected with the mutant vFL12Nsp1b70-5A when compared to pigs infected with vFL12 for 14 dpi (Fig. 6B) . In contrast, pigs infected with the mutant vFL12Nsp1aG90S had similar viral titers as well as viral RNA copies in serum when compared to the pigs infected with vFL12 (Fig. 6A, B) .
The TNF-a mRNA levels in PBMCs were enhanced in pigs infected with vFL12Nsp1b70-5A virus at 3 dpi when compared to the wild type vFL12 infection (Fig. 6C ). Pigs infected with the mutant vFL12Nsp1aG90S showed increased TNF-a protein levels in serum at 7 dpi when compared to pigs infected with wild type vFL12 (Fig. 6D) . However, at 10 dpi, both vFL12 and vFL12Nsp1aG90S groups had similar elevated levels of TNF-a (Fig. 6D) . In summary, the mutant vFL12Nsp1b70-5A virus replicated with reduced viral titers and the virus also up-regulated TNF-a mRNA levels at 3 dpi in infected pigs.
Discussion
PRRSV decreases the production of TNF-a during infection in vitro and in vivo (Calzada-Nova et al., 2011; Labarque et al., 2003; Lopez-Fuertes et al., 2000; Subramaniam et al., 2010; . Nsp1a and Nsp1b are important viral mediators that reduce TNF-a promoter activity in transient transfection assays . In this study, we identified critical amino acid residues in Nsp1a and Nsp1b that are important for TNF-a down-regulation. Subsequently, through reverse genetics, we generated two mutant PRRSV viruses that up-regulated TNF-a expression, particularly at mRNA level in infected macrophage cultures. These two mutant viruses replicated in cell culture with reduced viral titers. In infected pigs, one mutant virus with mutation in Nsp1b replicated with reduced viral titers in serum.
Several laboratories demonstrated that PRRSV infection leads to poor TNF-a response in serum and broncho-alveolar lavage fluid from infected pigs (Labarque et al., 2003; Thanawongnuwech et al., 2004; . Similarly, PRRSV infection actively inhibits TNF-a expression in macrophages and dendritic cells in vitro (Calzada-Nova et al. 2011; Lopez-Fuertes et al., 2000) . Previous results from our laboratory indicated that PRRSV cysteine proteases, Nsp1a and Nsp1b suppress TNF-a promoter by modulating the activity of specific transcription factors, NF-kB and Sp1, respectively . In this study, we sought to further characterize the down-regulatory effect by identifying the amino acid residues in Nsp1a and Nsp1b that reduce TNF-a production. Upon such identification, we pursued recovering PRRSV strains with mutations in those positions by reverse genetics and examining the mutants in infected animals for their ability to relieve TNF-a suppression.
A previous study had shown that active site mutations in Nsp1 cysteine proteases lead to failure of virus recovery by reverse genetics (Kroese et al., 2008) . Our result showed that the Nsp1 cysteine protease activities were not necessary for suppressing TNF-a promoter activity. This observation is consistent with previous findings that the Nsp1 cysteine proteases cleave only cis-substrates present at the end of respective proteins (Sun et al., 2009; Xue et al., 2010) . Therefore, it is less likely that Nsp1 cysteine protease activities degrade signaling molecules required for the TNF-a-induction pathway.
Screening of domain-specific mutations in Nsp1a revealed that the PCPa domain, but not the ZF domain, was primarily important for inhibiting TNF-a promoter activity. Five amino acid residues (Gly90, Asn91, Arg97, Arg100, and Arg124) on the surface of the PCPa domain were important for inhibiting the TNF-a promoter. Many mutations in the ZF domain of Nsp1a did not significantly relieve TNF-a suppression, which suggested that the ZF domain may not directly participate in inhibiting the TNF-a promoter activity. We were only able to recover mutant viruses with mutations at Nsp1a Gly90 residue. However, viruses with mutations at Nsp1a residues Asn91, Arg97, Arg100, and Arg124, were not viable, though they were found to be dispensable for PCPa protease activity. These amino acid residues may be important for other Nsp1a functions, such as viral transcription, replication and/or virion biogenesis (Fang and Snijder, 2010) . Unlike Nsp1a, all three domains of Nsp1b seem to be important for down regulating TNF-a promoter activity. One of Nsp1b mutant (70-5A) exhibits protein levels equivalent to wild type but did not reduce TNF-a promoter activity efficiently. In agreement with this, 70-5A mutant protein did not also reduce transcription driven by Sp1, which bind TNF-a promoter to activate transcription (Falvo et al., 2000) . The 70-5A mutation is located in a small linker domain of Nsp1b. The successful recovery of mutant virus in this position suggests that the amino acids at 70-74 position are not required for Nsp1b protease activity over Nsp1b-Nsp2 junction. It seems plausible that the Nsp1b linker domain may directly participate in the inhibition of Sp1 trans-activation or indirectly modulate the functions of the other Nsp1b domains to inhibit Sp1-dependent TNF-a transcription.
Previous studies demonstrated that PRRSV suppresses TNF-a expression at the transcriptional and post-transcriptional levels Thanawongnuwech et al., 2004) . PRRSV particularly inhibited the TNF-a transcription during early time points after infection in macrophages . We confirmed such previous finding in the present study. Both Nsp1 mutant virus infections showed enhanced TNF-a transcriptional activity at early times (12 h) post-infection. Particularly, the Nsp1b mutant virus significantly induced TNF-a mRNA levels at 12 h postinfection in infected macrophage cultures. In consistent with these in vitro observations, pigs infected with Nsp1b mutant virus also up-regulated TNF-a mRNA levels at 3 dpi in peripheral blood mononuclear cells.
When the growth characteristics of Nsp1 mutant viruses were examined, both viruses were moderately attenuated in growth in susceptible MARC-145 cells, which may be due to the effects in other Nsp1 functions such as transcription and replication. When we examined the growth of these mutant viruses in macrophages in vitro and in infected pigs, the growth of vFL12Nsp1b70-5A was severely compromised but the growth of vFL12Nsp1aG90S was affected to a minimal level. Even though vFL12Nsp1b70-5A mutant virus has ability to induce TNF-a mRNAs earlier than the wild type virus, it did not induce significant TNF-a protein at any time point after infection in vitro or in vivo. Hence, the crippled growth of vFL12Nsp1b70-5A in macrophages in vitro and in infected pigs is more likely due to loss of some other critical function of the protein important for viral progression.
The vFL12Nsp1aG90S mutant virus infection produced detectable levels of TNF-a protein in macrophages when compared to wild type virus infection. This suggests that in addition to its effect at the promoter level, Nsp1a also inhibits TNF-a production via a post-transcriptional mechanism. This is evident in animal studies in which vFL12Nsp1aG90S mutant virus induced TNF-a in serum of infected pigs at 7 dpi when compared to wild type vFL12 infected pigs. Additional experiments also revealed that, when over-expressed, Nsp1a reduces co-expressing TNF-a protein levels without affecting Internal Ribosome Entry Site (IRES)-dependent GFP expressed from a bi-cistronic mRNA. Further, in those experiments, Nsp1aG90S mutant protein did not efficiently reduce TNF-a protein levels expressed from the bi-cistronic construct when compared to the wild type protein.
In summary, the overall conclusions of this study are: (1) Nsp1a amino acid residue Gly90 is necessary for suppressing the TNF-a promoter activity and TNF-a protein levels during PRRSV infection; (2) Nsp1b amino acid residues at 70-74 are necessary for suppressing the TNF-a promoter activity; and (3) PRRSV-vFL12 strain with mutation at Nsp1b positions 70-74 produced significantly reduced viral titers in infected pigs, an information that may pave the way for new candidate attenuated live vaccines.
Materials and methods

Cells and viruses
RAW 264.7 cells, a murine macrophage cell line (ATCC) was maintained in RPMI-1640 supplemented with 10% fetal bovine serum (FBS). MARC-145 cells, an African green monkey kidney epithelial cell line (obtained from Dr. Will Laegreid, University of Illinois, Urbana-Champaign) was maintained in Dulbecco's modified eagle medium (DMEM)-low glucose supplemented with 10% FBS. BHK-21, baby hamster kidney epithelial cell line (ATCC) was maintained in DMEM-high glucose supplemented with 10% FBS. Primary swine macrophages were prepared from PBMCs as previously described . PRRSV vFL12 strain (GenBank ID: AY545985) and its mutant viruses were propagated and titrated in MARC-145 cells. Viral titers were calculated using the Reed and Muench method (Reed and Muench, 1938) . Viral plaque assays were performed in MARC-145 cells as previously described .
TNF-a promoter-luciferase reporter assay
Swine TNF-a promoter-luciferase reporter assay was carried out as previously described . RAW 264.7 cells were co-transfected with plasmids, pswTNF-luc (0.2 mg) and pRL-TK (10 ng) (Promega), and wild type or mutant Nsp1a/Nsp1b-expressing plasmid (1 mg) using DEAE-dextran (Sigma) by following a procedure described earlier . After 24 h of transfection, the reporter genes were stimulated with LPS (1 mg/mL) for 6 h. Firefly and renilla luciferase activities were measured using dual luciferase reporter assay system in GloMax 20/20 luminometer (Promega). Firefly luciferase units were normalized with renilla luciferase units. Relative luciferase units were calculated by dividing normalized firefly luciferase units measured from stimulated cells with those measured from unstimulated cells.
Plasmids construction
pIHA-Nsp1D268-297 plasmid was constructed by deleting thirty amino acids from 268 to 297 amino acid positions in the whole Nsp1 sequence (Gene Bank Accession No. AY545985). Plasmids expressing Nsp1a or Nsp1b (pIHA-Nsp1a and pIHANsp1b ) were used to introduce 3-6 amino acid alanine-scanning mutations. pIHA-Nsp1D268-297 plasmid was used to introduce point mutations in Nsp1a. Mutations were introduced into Nsp1 genes by PCR mutagenesis following the mega primer method (Sarkar and Sommer, 1990) .
In order to transfer Nsp1a and Nsp1b mutant sequences from pIHA constructs into pFL12 infectious clone (Truong et al., 2004) , we constructed an intermediate transfer vector pIHA-2757. The plasmid was constructed by cloning RsrII and SpeI restrictiondigested fragment of pFL12 infectious clone into pIHA empty vector . Nsp1a mutant sequences were cloned into pIHA-2757 using AccI and StuI restriction sites present within Nsp1a. Nsp1b mutant sequences were cloned into pIHA-2757 using AvrII and BsrGI restriction sites present within Nsp1b. Finally, the RsrII and SpeI digested fragment was transferred from the pIHA-2757 mutant plasmid into pFL12 infectious clone. The corresponding mutation in pFL12 plasmid was confirmed by sequencing.
Quantitative RT-PCR and ELISA TNF-a-specific quantitative PCR (qPCR) was performed as previously described . Briefly, total RNA fractions were prepared from mock-infected cells or cells infected with either vFL12 or mutant viruses using Trizol-LS reagent (Invitrogen). Complementary DNAs (cDNAs) were synthesized using oligo-dTs as primer. cDNAs were used as template in qPCR reactions to measure TNF-a or b-actin mRNAs using sequence-specific primers and probes .
PRRSV 3 0 untranslated region (UTR)-specific qRT-PCR was performed to detect viral RNAs in serum of infected pigs. Briefly, viral RNAs were isolated from 140 mL of serum using QIAamp viral RNA mini kit (Qiagen). Viral RNAs (4 mL) were used as template in quantitative reverse-transcription (RT)-PCR reaction using hot start-IT Probe one step qRT-PCR kit (USB, 75772). The following primers and probe were used in the reaction: forward primer ATGTGTGGTGAATGGCACTG, reverse primer GCATGGTTCTCGCCA-ATTAAA, Taqman probe 6-FAM-TCACCTATTCAATTAGGGCGACCG-TAMRA. The cycling conditions employed were as follows: reverse transcription at 50 J C for 30 min, initial enzyme activation at 95 J C for 2 min, denaturation at 95 J C for 15 s followed by annealing/ extension at 60 J C for 60 s. Denaturation and annealing/extension steps were repeated for total of 45 cycles.
To measure the TNF-a protein levels in the supernatant of mock-infected or virus-infected cells, a commercial swine TNF-aspecific ELISA was used (Pierce/Invitrogen).
Western blotting
Cellular protein lysates were prepared in either radio-immunoprecipitation assay buffer or cell-lysis buffer as described elsewhere (Alcaraz et al., 1990; Beura et al., 2010) . Equal amounts of total protein were resolved in 12% Sodium dodecyl Sulfate (SDS)-polyacrylamide gel electrophoresis and transferred on Polyvinylidene fluoride (PVDF) membrane. The membrane was blotted with rabbit polyclonal antibodies specific for Nsp1 or mouse monoclonal antibodies specific for b-actin (Santacruz) for overnight at 4 J C. The membranes were treated with Horse Radish Peroxidase (HRP)-conjugated anti-rabbit or anti-mouse IgG antibodies (KPL) for 1 h at RT and signals were obtained with chemiluminescence substrates (Thermo scientific).
In vitro transcription, electroporation and recovery of mutant viruses
Capped in vitro transcripts (IVTs) were prepared from wild type or mutant pFL12 infectious clones as previously described Truong et al., 2004) . IVTs were electroporated into MARC-145 or BHK-21 cells by following a procedure described earlier . After 1-2 day post-electroporation, the replication of mutant virus was confirmed by immunofluorescence using anti-N monoclonal antibodies (SDOW17, NVSL-USDA). The success of viral recovery was assessed by spread of cytopathic effect in electroporated MARC-145 cells. The supernatants from electroporated BHK-21 cells were transferred on to PBMC-derived macrophages to propagate recovered viruses.
Viral growth kinetics and in vitro infection studies
For multi-step growth kinetics, MARC-145 cells were cultured in 96-well plates two days before infection. On the third day, cells were infected with vFL12 wild type or mutant viruses at 0.1 multiplicity of infection (m.o.i.) in triplicates. At 6, 12, 24, 48, 72 , 96 h post-infection, supernatants were collected and viruses were titrated in MARC-145 cells. The viral titers were calculated using Reed and Muench method (Reed and Muench, 1938) . For measuring TNF-a mRNA and protein responses in vitro, PBMC-derived macrophages were infected with vFL12 wild type or mutant viruses at 0.1 m.o.i. At 12, 24, 36 and 48 h post-infection, cells were collected in Trizol-LS (Invitrogen) for mRNA quantification. Supernatants were collected to measure TNF-a protein and viral titers.
Animal experiments
Four-week old PRRSV-negative pigs (n ¼3 each group) were infected with vFL12 wild type or mutant strains at 10 5.1 TCID 50 / 2 mL intra-muscularly. At 3, 7, 10, 14, 21 day post-infection (dpi), serum was collected to determine viremia and TNF-a protein levels by viral titration and ELISA, respectively. Similarly, PBMCs (1 Â 10 6 cells/aliquot) were collected in Trizol-LS for mRNA quantification.
Statistical analysis
The significance in difference between means of two treatment groups was tested using one-tailed unpaired student's t-test. A 'p' value of less than 0.05 was considered significant. Analyses were performed using Prism 5 (Graphpad).
